Bailard Inc. drastically reduced its stake in Regeneron Pharmaceuticals, offloading 69.9% of its shares in the first quarter.

Fintel reports that on July 21, 2025, Truist Securities initiated coverage of Alnylam Pharmaceuticals (NasdaqGS:ALNY) with a Buy recommendation. Analyst Price Forecast Suggests 6.19% Upside As of July ...

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Despite some near-term revenue growth, HRTX's future is uncertain. Click here to find out why HRTX stock is a Hold.

Q1 2025 delivered first positive adjusted EBITDA result since 2021 and guided to a break-even adjusted EBITDA result for ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...